NewEdge Wealth LLC Acquires 7,231 Shares of National Health Investors, Inc. $NHI

NewEdge Wealth LLC lifted its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 48.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,054 shares of the real estate investment trust’s stock after acquiring an additional 7,231 shares during the quarter. NewEdge Wealth LLC’s holdings in National Health Investors were worth $1,783,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Principal Financial Group Inc. boosted its holdings in shares of National Health Investors by 1.9% in the 4th quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock worth $127,386,000 after buying an additional 30,968 shares during the last quarter. Sound Income Strategies LLC increased its holdings in National Health Investors by 6.5% during the fourth quarter. Sound Income Strategies LLC now owns 256,898 shares of the real estate investment trust’s stock worth $20,595,000 after buying an additional 15,638 shares during the last quarter. Aberdeen Group plc increased its holdings in National Health Investors by 73.7% during the fourth quarter. Aberdeen Group plc now owns 45,355 shares of the real estate investment trust’s stock worth $3,464,000 after buying an additional 19,241 shares during the last quarter. Forty three Eighteen Advisors LLC purchased a new stake in National Health Investors during the first quarter worth about $2,005,000. Finally, M&T Bank Corp bought a new stake in National Health Investors in the fourth quarter worth about $2,996,000. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Trading Down 0.1%

Shares of NHI opened at $80.49 on Monday. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The business has a 50-day moving average of $75.02 and a 200 day moving average of $79.74. The firm has a market cap of $3.90 billion, a P/E ratio of 25.96, a price-to-earnings-growth ratio of 3.62 and a beta of 0.51. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s dividend payout ratio (DPR) is currently 118.71%.

Insider Activity

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction dated Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the transaction, the chief executive officer owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have weighed in on NHI shares. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft lowered their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Finally, BMO Capital Markets reduced their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday, June 15th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $83.86.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.